Literature DB >> 793085

Immunology of bronchial carcinoma.

D A Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 793085      PMCID： PMC470466          DOI： 10.1136/thx.31.5.493

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  84 in total

1.  Antitumour immunity--1. Differential response of neuraminidase-treated and x-irradiated tumour vaccine.

Authors:  P K Ray; V S Thakur; K Sundaram
Journal:  Eur J Cancer       Date:  1975-01       Impact factor: 9.162

2.  Prolonged survival in bronchogenic carcinoma associated with HL-A antigens W-19 and HL-A5: a preliminary report.

Authors:  A L Dellon; G N Rogentine; P B chretien
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

3.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

4.  Immunological studies in nephrotic syndrome associated with extrarenal malignant disease.

Authors:  M G Lewis; L W Loughridge; T M Phillips
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

5.  Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera.

Authors:  I Hellström; K E Hellström; G A Warner
Journal:  Int J Cancer       Date:  1973-09-15       Impact factor: 7.396

6.  Carcinoma of the colon and rectum: circulating malignant cells and five-year survival.

Authors:  J D Griffiths; J A McKinna; H D Rowbotham; P Tsolakidis; A J Salsbury
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

7.  Production of 19S and 7S antibodies by cancer patients.

Authors:  A G Levin; M P Cunningham; A K Steers; D G Miller; C M Southam
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

8.  Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens.

Authors:  H S Nelson
Journal:  J Natl Cancer Inst       Date:  1969-05       Impact factor: 13.506

9.  Antibody-producing capacity in human cancer.

Authors:  A K Lee; M Rowley; I R Mackay
Journal:  Br J Cancer       Date:  1970-09       Impact factor: 7.640

10.  Overcoming some limiting factors in tumour immunotherapy.

Authors:  O Fakhri; J R Hobbs
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640
View more
  5 in total

1.  Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1978-08       Impact factor: 9.139

2.  Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG.

Authors:  B H Stack; N McSwan; J M Stirling; D J Hole; D Parratt; W G Spilg; C R Gillis; I McHattie; A G Green; R G White; M A Turner
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

3.  Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.

Authors:  H M Jansen; T H The; N G Orie
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

4.  The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; G Pastoor; N G Orie
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

5.  Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.

Authors:  B H Stack; N McSwan; J M Stirling; D J Hole; W G Spilg; I McHattie; J A Elliott; C R Gillis; M A Turner; R G White
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.